Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970101_sep96_decls31_0008.txt
Subject: REQ FOR DETERMINATION INFORMED CONSENT DRUG AND VACCINES
Unit: OTSG
Parent Organization: HSC
Box ID: BX003201
Folder Title: REQUESTS FOR DETERMINATION INFORMED CONSENT DRUGS
Document Number: 1001
Folder Seq #: 16
September 5, 1990
Subject: BB-IND 161 - Pentavalent Botulinum Toxoid
Director
Center for Biologics Evaluation and Research
Division of Biological Investigational New Drugs (HFB-230)
Food and Drug Administration
8800 Rockville Pike
Bethesda, Maryland 20892
Dear Sir:
We authorize the FDA to cross-reference our Investigational New Dru@
application BB-IND 161 when reviewing submissions for the same product from the
Department of the Army, Office of the Surgeon Ceneral (OTSG).
We also authorize the Department of the Army, OTSG, to cross-reference BB-
IND 161.
Sincerely,
Paul A. Blake, M.D., M.P.H.
Chief, Enteric Diseases Branch
Division of Bacterial and Mycotic Diseases
Center for Infectious Diseases
cc @. E. Brandt
J. Becher
ATTACHTA,ENT 2
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 16 f:/Week-36/BX003201/REQUESTS FOR DETERMINATION INFORMED CONSENT DRUGS/req for determination informed consent drug and :12249609312932
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = REQUESTS FOR DETERMINATION INFORMED CONSENT DRUGS
Folder Seq # = 16
Subject = REQ FOR DETERMINATION INFORMED CONSENT DRUG AND
Document Seq # = 1001
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996